BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
5.69
+0.42 (7.97%)
Jun 6, 2025, 2:54 PM - Market open

BioLineRx Market Cap

BioLineRx has a market cap or net worth of $18.87 million as of June 6, 2025. Its market cap has decreased by -63.87% in one year.

Market Cap
18.87M
Enterprise Value
5.39M
1-Year Change
-63.87%
Ranking
Category
Stock Price
$5.69

Market Cap Chart

Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $18.87M, a decrease of -44.18%. That is a compound annual growth rate of -3.61%.

History

DateMarket Cap% Change
Jun 5, 202518.87M-19.67%
Dec 31, 202423.49M-79.62%
Dec 31, 2023115.26M305.33%
Dec 29, 202228.44M-71.41%
Dec 30, 202199.46M66.19%
Dec 31, 202059.85M124.34%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 31, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 682.28B
Johnson & Johnson 368.73B
AbbVie 331.01B
Novo Nordisk 324.15B
UnitedHealth Group 273.03B
Abbott Laboratories 230.51B
Novartis AG 229.87B
AstraZeneca 226.47B
Market Cap Rankings